235 related articles for article (PubMed ID: 35618158)
1. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy [Biochimie 200 (2022) 44-59].
Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
Biochimie; 2022 Sep; 200():44-59. PubMed ID: 35618158
[No Abstract] [Full Text] [Related]
2. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review).
Cutando A; López-Valverde A; DE Vicente J; Gimenez JL; Carcía IA; DE Diego RG
Oncol Lett; 2014 Apr; 7(4):923-926. PubMed ID: 24944644
[TBL] [Abstract][Full Text] [Related]
3. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
[TBL] [Abstract][Full Text] [Related]
4. Pain control by melatonin: Physiological and pharmacological effects.
Chen WW; Zhang X; Huang WJ
Exp Ther Med; 2016 Oct; 12(4):1963-1968. PubMed ID: 27698681
[TBL] [Abstract][Full Text] [Related]
5. Melatonin: Nature's most versatile biological signal?
Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
[TBL] [Abstract][Full Text] [Related]
6. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells.
Cui P; Luo Z; Zhang H; Su Y; Li A; Li H; Zhang J; Yang Z; Xiu R
J Pineal Res; 2006 Nov; 41(4):358-62. PubMed ID: 17014693
[TBL] [Abstract][Full Text] [Related]
7. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling.
Wiesenberg I; Missbach M; Carlberg C
Restor Neurol Neurosci; 1998 Jun; 12(2-3):143-50. PubMed ID: 12671309
[TBL] [Abstract][Full Text] [Related]
8. The validity of melatonin as an oncostatic agent.
Panzer A; Viljoen M
J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
[TBL] [Abstract][Full Text] [Related]
9. A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity.
Cutando A; Aneiros-Fernández J; López-Valverde A; Arias-Santiago S; Aneiros-Cachaza J; Reiter RJ
Arch Oral Biol; 2011 Oct; 56(10):944-50. PubMed ID: 21459362
[TBL] [Abstract][Full Text] [Related]
10. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
Blask DE; Sauer LA; Dauchy RT
Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
[TBL] [Abstract][Full Text] [Related]
12. Melatonin membrane receptors in peripheral tissues: distribution and functions.
Slominski RM; Reiter RJ; Schlabritz-Loutsevitch N; Ostrom RS; Slominski AT
Mol Cell Endocrinol; 2012 Apr; 351(2):152-66. PubMed ID: 22245784
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and cancer: current knowledge and its application to oral cavity tumours.
Cutando A; Aneiros-Fernández J; Aneiros-Cachaza J; Arias-Santiago S
J Oral Pathol Med; 2011 Sep; 40(8):593-7. PubMed ID: 21284745
[TBL] [Abstract][Full Text] [Related]
14. Melatonin in pathogenesis and therapy of cancer.
Ravindra T; Lakshmi NK; Ahuja YR
Indian J Med Sci; 2006 Dec; 60(12):523-35. PubMed ID: 17130668
[TBL] [Abstract][Full Text] [Related]
15. A Review of Melatonin, Its Receptors and Drugs.
Emet M; Ozcan H; Ozel L; Yayla M; Halici Z; Hacimuftuoglu A
Eurasian J Med; 2016 Jun; 48(2):135-41. PubMed ID: 27551178
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
17. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship.
Carlberg C; Wiesenberg I
J Pineal Res; 1995 May; 18(4):171-8. PubMed ID: 8531047
[TBL] [Abstract][Full Text] [Related]
18. Pineal gland, melatonin and cancer. NEL Review.
Karasek M; Pawlikowski M
Neuro Endocrinol Lett; 1999; 20(3-4):139-144. PubMed ID: 11462104
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand.
Wiesenberg I; Missbach M; Kahlen JP; Schräder M; Carlberg C
Nucleic Acids Res; 1995 Feb; 23(3):327-33. PubMed ID: 7885826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
